State Secretary for Economic Affairs and Climate Change visited Ncardia and MimetasWednesday, November 15, 2017
Mrs Keijzer visited two SMEs, Ncardia en Mimetas, both situated within the Bio Science Park in Leiden, on the afternoon of the Day of the Entrepreneur.
Ncardia uses human stem cells to create billions of heart muscle cells which in turn are used to test medicines. This innovative technique maps the side effects of the tested medicines and is also capable of evaluating the efficacy of drugs for cardiovascular diseases.
Mimetas is developing the new technology: 'Organ-on-a-Chip'. This relates to an advanced culture plate (the OrganoPlate ©) which is used to farm tiny 3D fragments of human tissue or organs. By applying drugs to these tissue fragments it is possible to be better able to predict the effects of medication on humans. This renders obsolete the need to experiment with test animals while also ensuring substantial cost savings.
On Friday Ncardia also celebrated the close of its 2nd investment round. To mark the occasion Mrs Keijzer presented Ncardia's CEO, Stefan Braam, with the corresponding 'tombstone' award.